These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8785706)

  • 1. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
    Cancer Gene Ther; 1996; 3(1):18-23. PubMed ID: 8785706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
    Cancer Gene Ther; 1995 Dec; 2(4):263-71. PubMed ID: 8548580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18.
    Steele C; Sacks PG; Adler-Storthz K; Shillitoe EJ
    Cancer Res; 1992 Sep; 52(17):4706-11. PubMed ID: 1324791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme-mediated in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16.
    Lu D; Chatterjee S; Brar D; Wong KK
    Cancer Gene Ther; 1994 Dec; 1(4):267-77. PubMed ID: 7627817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of ribozymes that target stathmin, a major regulator of the mitotic spindle.
    Mistry SJ; Benham CJ; Atweh GF
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):41-9. PubMed ID: 11258620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector.
    Gibson SA; Pellenz C; Hutchison RE; Davey FR; Shillitoe EJ
    Clin Cancer Res; 2000 Jan; 6(1):213-22. PubMed ID: 10656452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.
    Sakamoto N; Wu CH; Wu GY
    J Clin Invest; 1996 Dec; 98(12):2720-8. PubMed ID: 8981917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
    Wiechen K; Zimmer C; Dietel M
    Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of anti-HPV 16 E7-ribozyme in CV-1 cell lines.
    Huang Y; Kong Y; Wang Y; Qi G; Lu C
    Chin J Biotechnol; 1996; 12(4):215-20. PubMed ID: 9187492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
    Weinberg MS; Ely A; Passman M; Mufamadi SM; Arbuthnot P
    Oligonucleotides; 2007; 17(1):104-12. PubMed ID: 17461767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.
    Shin KS; Sullenger BA; Lee SW
    Mol Ther; 2004 Aug; 10(2):365-72. PubMed ID: 15294183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells.
    Feng Y; Kong YY; Wang Y; Qi GR
    Biol Chem; 2001 Apr; 382(4):655-60. PubMed ID: 11405228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells.
    Zheng YF; Zhang JR
    Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.